Emily Aaronson, MD is a Patient Safety and Quality clinical fellow in the Massachusetts General Hospital Department of Emergency Medicine. She recently completed a year as a Chief Resident in the Harvard Affiliated Emergency Medicine Residency Program at Brigham & Women’s Hospital/Massachusetts General Hospital. Before medical school, Dr. Aaronson worked for H*Works on the consulting arm of the Advisory Board Company. She received her BA from George Washington University, and her MD from McMaster University, Michael G. DeGroote School of Medicine in Ontario. She has conducted grant funded research and published on quality in emergency care. Among her work on several Brigham and Massachusetts General Hospital committees, she served as a co-chair for the Housestaff Patient Safety and Quality Committee at Brigham & Women’s Hospital. As a resident, Dr. Aaronson spearheaded a departmental process improvement project centered on patient engagement in the Emergency Department, and worked with hospitals in Haiti and Ghana on quality improvement projects. As a fellow, she is focusing on work in improvements in Sepsis Care, Patient Engagement and mitigating safety risks in the Emergency Department.
Melissa Abraham, in her role as the Director for the MGH Division of Clinical Research’s Research Ethics Consultation Unit, uses her 15 year background as a member and Chair of the Partners IRB and a fellow in Bioethics at HMS, to consult with investigators to improve the quality of IRB submissions and reviews, by discussing the ethical underpinnings of institutional and regulatory requirements with researchers, and assisting in the communication of QI, social science and behavioral research methods and practices to the IRB. She teaches bioethics at HMS and has a psychotherapy practice. Melissa has a degree in Epidemiology from the Harvard School of Public Health, and a doctorate in Clinical Psychology from Northwestern University Medical School.
Aalok Agarwala collaborates on the Operating Room Black Box project with Ariadne Labs to test new ways of gathering patient data and environmental information to reduce errors, improve quality, and better understand team dynamics in the operating room. This project will be piloted at Massachusetts General Hospital. Dr. Agarwala also collaborates with Ariadne Labs and the Emergency Manual Implementation Collaborative in the national effort to increase implementation of the Operating Room Crisis Checklist.
Dr. Arbour is a physician anthropologist who implements and evaluates interdisciplinary interventions to promote child development globally, using a combination of experimental, ethnographic and quality improvement methodologies. She has particular interests in methods for adapting evidence-based practices across diverse contexts and populations, and in scale.
Dr. Arbour’s expertise includes adapting continuous quality improvement methods (CQI) to a diversity of disciplines and contexts to improve clinical, public health and education outcomes. She leads integration of CQI methods in:
• the US Department of Maternal and Child Health’s first national quality improvement collaborative for home visiting services (HV CoIIN, Home Visiting Collaboration for Improvement and Innovation Network),
• the adaptation and spread of Project DULCE, an intervention to address social determinants of health and promote understanding of healthy development among families with infants 0 to 6 months in pediatric clinics in 3 states,
• a community-level collaboration aimed at improving child development in two high-poverty neighborhoods in NYC
• a school-based intervention to improve children’s health and learning in public preschools in Chile (Un Buen Comienzo, A Good Start), conducted as a cluster-randomized trial in a first phase (2008-2011) and quasi-experimental design in a latter expansion (2011-present).
She has led quality improvement capacity-building efforts, formal curriculum development and delivery with professionals, paraprofessionals and community members. She co-designed and teaches the DOHVE CQI practicum for MIECHV state leads.
Dr. Arbour holds a BA in Biological Anthropology from Swarthmore College, an MD from Harvard Medical School and an MPH from the Harvard School of Public Health.
Alex Arriaga is an Assistant Professor of Anaesthesia at Harvard Medical School and Anesthesiologist for the Brigham and Women’s Hospital. He completed his undergraduate studies from Columbia University and graduated from medical school with Honors in Research from Cornell University. He completed two years of categorical general surgery residency at Thomas Jefferson University Hospital. He has Master of Public Health and Doctor of Science degrees from Harvard University. He completed his clinical residency in anesthesiology at the Brigham and Women’s Hospital with Distinction in Research. He was a member of the faculty at the University of Pennsylvania for two years. He has presented locally and nationally. Dr. Arriaga has over thirty co-authored publications, including two book chapters as senior author. His peer-reviewed published work includes a first-author original research study in the New England Journal of Medicine (NEJM), three first-author studies in the Annals of Surgery, and two second-author publications in Anesthesiology. He is one of seven members of the Patient Safety Editorial Board for the American Society of Anesthesiologists. His academic interests include health services research in crisis management, patient safety, perioperative care, and quality improvement, with a focus on the fields of surgery and anesthesiology.
Stan Ashley is a GI Surgeon with interests in GME, CPD, and quality improvement. He has served as a member of a Ariadne task force focused on reducing patient safety risk from health systems expansion and currently is involved with the surgical coaching project.
Michael Barnett is a primary care physician and health services researcher. His research focuses on the quality of health care delivery with particular interests in the primary-specialty care interface, low-value care, and innovations in health care delivery.
Salma Batool-Anwar’s research focuses on integrating palliative care services for critically ill patients in intensive care units. In addition, she is interested in studying the public health impact of variety of sleep disorders.
Amy Baughman, in her role as Director of Quality Improvement for the Geriatrics and Extended Care Service at Veteran Affairs (VA) Boston, utilizes her clinical research training in systems redesign and quality improvement. Her work focuses on patient flow, care transitions, and medication reconciliation between hospital and sub-acute care facilities at the VA Boston. She seeks collaboration in the quality improvement space and hopes to facilitate other collaborations between Ariadne Labs and the VA Boston.
Benjamin Bearnot is a Massachusetts General Hospital-trained physician-investigator looking for opportunities in health system innovation and implementation science. He enjoys employing existing methods, and developing new ones, to improve the health of communities through adaptive execution of evidence-based interventions. He is particularly passionate about transforming care for patients with opioid addiction and other substance use disorders, who suffer similar stigma to HIV-infected populations he worked with in New York City and Durban, South Africa previously. He now practices internal medicine at the Massachusetts General Hospital Charlestown community health center, attends on the addiction consult service at Massachusetts General Hospital, and is participating in innovation and community health leadership fellowships.
As the Chief Medical Officer at Ariadne Labs, Evan Benjamin, MD, MS, FACP, provides oversight, guidance, and support to Ariadne Labs research faculty, ensuring that Ariadne’s findings are supported by rigorous evidence and result in clinically meaningful change. Evan mentors faculty and research scientists and works with individuals to enhance faculty research. In addition, Evan works in close collaboration with Ariadne’s founder, Dr. Atul Gawande, to develop and expand Ariadne’s strategic partnerships, and to raise the Ariadne Labs profile as a global leader in health systems innovation.
Prior to becoming CMO at Ariadne Labs, Evan was Senior Vice President for Population Health and Quality, Baystate Health, a $2B revenue integrated delivery system in Massachusetts where he oversaw clinical quality, patient safety, population health, infection control, a 100 physician primary care practice, and Information Technology for the 5 hospital system. He was responsible for bringing reliability and efficiency to the health system using modern tools of improvement science.
He is an Associate Professor of Medicine at Harvard Medical School with a secondary appointment at the Harvard T.H. Chan School of Public Health and is also an Adjunct Professor of Medicine at Tufts University. He is active in scholarly research in healthcare delivery and speaks and consults nationally on issues related to improving healthcare delivery. Evan is faculty for the Institute for Healthcare Improvement (IHI) where he teaches leadership and improvement and sits on numerous national boards and healthcare panels including the National Academy of Medicine, the American Hospital Association, CMS and others. He currently serves as a board member for the UMass Memorial Health Care System.
Evan received a BA in Chemistry from Williams College, an MD from Case Western Reserve University, and an MS in Healthcare Delivery Science from Dartmouth College. He completed an internal medicine residency at Yale-New Haven Hospital.
Rachelle Bernacki leads the Serious Illness Community of Practice and serves as the faculty development lead in the Serious Illness, Vital Talk, and Center to Advance Palliative Care collaborative program. This program will nationally scale communication, implementation, and training efforts in order to strengthen health systems with innovative and comprehensive solutions in serious illness care that have a sustained impact. She is also the Project Director for the Dana-Farber Cancer Institute randomized controlled trial and the integrated Care Management Program, which focuses on high-risk primary care patients. She plays a key role at Ariadne Labs in the development, implementation and evaluation of a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. Dr. Bernacki was named a Cambia Sojourns Leadership Scholar in 2015.
William Berry serves as the Strategic Advisor to the Chief Medical Officer and as Associate Director of Ariadne Labs. In 2012, together with Atul Gawande, he co-founded the Labs and served as Chief Medical Officer for its first five years. For the last year, he has been the Chief Implementation Officer and created the Implementation Platform. He began working with Dr. Gawande in 2005 and initially served as the Boston Project Director of the WHO Safe Surgery Saves Lives Program. Dr. Berry is a retired cardiothoracic surgeon with interests in patient safety and implementation in healthcare.
Amy Billett is the Principal Investigator of a project through Ariadne Labs called “Making It Easier to Care for Your Central Line at Home: A Standardized Process to Reduce Ambulatory Central Line Associated Bloodstream Infections (CLABSI).” This project is developing a model to decrease infection rates in pediatric hematology/oncology patients by ensuring that patients and their families develop the confidence and skills to perform best practice central line care at home correctly, every time with decreased distress. Preliminary results demonstrate that the project is feasible and well received by families, and suggest a decrease in infection rates. The team is now seeking to apply this model to high risk medication administration in the home.
Asaf Bitton is a practicing primary care physician and assistant professor of medicine and health care policy at Harvard Medical School and Brigham & Women’s Hospital. He leads Ariadne Labs’ work around measuring and improving primary care performance as part of the Primary Health Care Performance Initiative (PHCPI), a joint effort with the Bill and Melinda Gates Foundation, The World Bank, The Results for Development Institute, and Ariadne Labs. Dr. Bitton is also Senior Advisor for the Comprehensive Primary Care Initiative Center for Medicare and Medicaid Innovation in Washington, DC.
Susan Block is a Senior Consultant to the Serious Illness Care Program at Ariadne Labs, a joint center for health care innovation at Brigham & Women’s Hospital and Harvard T.H. Chan School of Public Health and Professor of Psychiatry and Medicine at Harvard Medical School. She founded the program in 2011, and served as its Director until 2017. In addition, She was the Founding Chair of the Department of Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute and Brigham & Women’s Hospital, and Founding Co-Director of the Harvard Medical School Center for Palliative Care, a program she and her husband, Andy Billings led for 17 years. Dr. Block received her AB from Stanford University, her MD from Case Western Reserve University School of Medicine, and completed residencies in both internal medicine and psychiatry at Beth Israel Deaconess Medical Center in Boston. She is board-certified in both fields. Dr. Block has been a national leader in the development of the field of palliative medicine, has led major innovative educational and quality improvement projects in a variety of areas, is known internationally as an expert in medical education, faculty development, and health system change, and has contributed to research in medical education, palliative care, psychooncology, and health system change. She is the author of over 200 publications and has won numerous awards for education, research and leadership.
Eric Buehrens is CEO of the Lean Enterprise Institute, a nonprofit devoted to improving work through application of lean principles in manufacturing, healthcare and many other industries. He is Instructor in Health Policy and Management at the Harvard T.H. Chan School of Public Health, and served in executive roles in academic medicine for twenty years, as COO and Interim CEO of Beth Israel Deaconess Medical Center, Executive Dean for Administration at Harvard Medical School, Deputy Provost for Administration at Harvard University, and as EVP and COO of Reliant Medical Group, a multi-specialty group practice.
Eric has led strategic planning processes as an executive and consultant, sponsored many patient safety and continuous improvement initiatives in healthcare, and is deeply committed to building learning organizations. He advises a number of healthcare startups and provides consultation and executive coaching to leadership teams in healthcare and higher education.
Richard Cash’s research interests include scaling health programs. He conducted clinical trials of oral rehydration therapy on adults and pediatric cholera patients and interventions to scale up programs especially in diarrhea management. Dr. Cash has also developed programs to assist low and middle income countries’ scientists in honing their research skills and directs a program and workshops on research ethics.
Christy Cauley, MD, MPH is a faculty member in the Safe Surgery Program at Ariadne Labs. Her research focuses on patient centered outcomes and utilization of surgery in patients with serious illness. She helped develop and test a communication guide to improve surgical decision-making before emergency surgical interventions in patients with serious illness through funding from the Program for Cancer Outcomes Research Training Fellowship with the National Cancer Institute.
Dr. Cauley is a staff surgeon at Massachusetts General Hospital and Harvard Medical School in the Division of General Surgery with subspecialty training in Colon & Rectal Surgery. Christy received her B.S. from Purdue University, her M.D. at Indiana University, and her Masters in Public Health from Harvard University. She completed residency training in general surgery at Massachusetts General Hospital in Boston, MA followed by Colorectal Surgery fellowship training at Cleveland Clinic in Cleveland, OH.
Dr. Ann Celi cares for women after hypertensive pregnancy in the Brigham and Women’s Hospital Cardiometabolic Clinic in Maternal Fetal Medicine, a postpartum transition clinic that cares for and manages patients during the immediate postpartum period and transitions them to primary care. It opened its doors in October of 2011 and has cared for over 600 women creating new quality improvement efforts and an extensive educational outreach to interdisciplinary faculty and staff as well as trainees, medical students and nurses. Educated at Wellesley College, Harvard Medical School, and Harvard School of Public Health, she trained at Massachusetts General Hospital and Children’s Hospital in Internal Medicine and Pediatrics.
Often in collaboration with the Preeclampsia foundation, Dr. Celi has been actively engaged in education of patients and the general public through development of patient education materials and appearances on newspaper, radio, magazine, and social media appearances.
Dr. Chatterjee is a med-peds trained primary care and addiction medicine physician physician at several shelter-based clinics through Boston Health Care for the Homeless Program. His areas of clinical and research interest include innovative treatment models for opioid use disorder in vulnerable populations, and interventions on social determinants of health, such as food insecurity.
Alyna Chien’s area of research expertise is in the relationship between the structure of the health care system, the incentives and price information that doctors and patients face, and resulting health care quality and spending, particularly for vulnerable populations. Her work has shown that incentives can improve preventive and chronic disease care for adult and pediatric patients in mixed and low-income populations. Dr. Chien’s current projects include examining the structure of large health care organizations and the quality of pediatric health care they provide, understanding spending variation for “shoppable” conditions (childbirth, breast cancer and prostate cancer), understanding how medical providers respond to patient’s social needs, and describing care quality and spending among children with disabilities.
Isaac Chua received his BA in Music from Rice University and MD from The University of Texas Health Science Center – Houston, where he completed a scholarly concentration in the Medical Humanities. He completed his residency in Internal Medicine at Dartmouth Hitchcock Medical Center and a fellowship in Hospice and Palliative Medicine at Massachusetts General Hospital/Dana Farber Cancer Institute. He is currently a CRICO/Harvard Medical School Patient Safety and Quality Fellow at Dana Farber Cancer Institute, where he practices Palliative Care. His academic interests include improving teamwork, digital health application, and opioid safety within Palliative Care.
Srinivas Emani is an Instructor in Medicine at the Laboratory for Computer Science at Massachusetts General Hospital and Associate Bioinformaticist in the Division of General Internal Medicine at Brigham and Women’s Hospital. His research interests are in the areas of patient engagement, patient portals, physician use of electronic health records, and ambulatory patient safety. In these areas, Dr. Emani is specifically interested in the application of innovation theories and social science theories to describe and explain individual and organizational perceptions, behaviors and processes. He is also interested in the role of evaluation frameworks such as the REAIM framework to assess and evaluate the generalizability of healthcare interventions.
Nic is chief science and technology officer at Ariadne Labs and oversees the computer-, data-, and implementation sciences teams. He is a cross-discipline specialist who has played key roles in building teams and pioneering innovation at technology and pharmaceutical companies. He has almost two decades of front line operating experience leading R&D teams, corporate strategy, innovation leadership, digital marketing/branding, business development, and strategic alliances.
Most recently, at the discretion of PerkinElmer’s CEO, Nic drove a new approach to innovation by establishing a new, semi-secret innovation lab and by leading the corporate cloud and IOT strategies. Prior to that, He was CEO and founder of Wingu, which was one of Google’s first venture investments in health technology (acquired by PerkinElmer in 2013). He also played early leadership and technical roles at Infinity Pharmaceuticals and TransForm pharmaceuticals. Nic began his career in the Human Genome Project as an engineer in the B.L.A.S.T. lab of Warren Gish.
Nic earned BS degrees in biology and psychology from the University of Rochester, an MS in Cell Biology, an MS in Computer Science, and an MBA in healthcare from Yale School of Management.
David Frank, MD, PhD is the Medical Director for Patient Safety at the Dana-Farber Cancer Institute. Dr. Frank oversees all patient level safety and quality issues, infection control, and patient complaints concerning the quality of care. He also oversees the continual monitoring of the professional practice of all physicians, nurse practitioners (NPs), and physician assistants (PAs). In addition, Dr. Frank chairs the Institute’s Pharmacy and Therapeutics Committee, and spearheads efforts in optimizing medication safety. In all of these roles, he not only helps lead the response to safety events that occur, but he also helps analyze “near misses” and conducts proactive risk assessments to develop systems-level solutions to prevent errors before they can occur.
Dr. Frank, who attended Stuyvesant High School in New York, received his undergraduate degree at MIT, and his MD and PhD from Yale. He was subsequently an intern, resident, and chief resident in internal medicine at Yale, after which he trained in medical oncology at the Dana-Farber Cancer Institute. In addition to his safety roles, Dr. Frank directly cares for patients with hematologic malignancies, runs a laboratory developing novel targeted signal transduction inhibitors, and teaches at Harvard Medical School.
Erik Fromme, MD, MCR, Faculty, Serious Illness Care Program.
Ishani Ganguli received her AB, MD, and MPH from Harvard University. She trained in Internal Medicine/Primary Care and completed fellowship in health policy and management at Massachusetts General Hospital. During fellowship, she led hospital-wide initiatives on patient education and patient-reported outcome measures while practicing primary care at the Massachusetts General Hospital Ambulatory Practice of the Future. She has since joined the faculty at Brigham & Women’s Hospital and Harvard Medical School – here, she studies health policy and practices at Brigham’s Advanced Primary Care Associates. Ishani is also a journalist who has written about science and health care for The Boston Globe, Reuters, The New York Times, and The Washington Post, among other publications. She is interested in how health policy, care delivery, and the media shape patient and clinician decision-making and, in turn, the costs and quality of health care.
Atul Gawande is the Executive Director of Ariadne Labs. He is also a surgeon, professor, writer, and public health researcher. He practices general and endocrine surgery at Brigham and Women’s Hospital, is professor in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health, and Samuel O. Thier Professor of Surgery at Harvard Medical School. Atul is also Chairman of Lifebox, a nonprofit reducing surgical deaths globally.
An influential writer, Atul has been a staff writer for The New Yorker magazine since 1998 and has written four New York Times bestselling books: Complications, which was a finalist for the National Book Award in 2002; Better, which was selected as one of the 10 best books of 2007 by Amazon.com; The Checklist Manifesto in 2009, and Being Mortal in 2014. He has received numerous awards including two National Magazine Awards, Academy Health’s Impact Award for highest research impact on health care, a MacArthur Genius Award, and the Lewis Thomas Award for writing and science.
Atul earned a BAS from Stanford University, an MA in philosophy, politics, and economics from Balliol College at Oxford University, an MD from Harvard Medical School, and an MPH from the Harvard School of Public Health.
Roya Ghazinouri PT, DPT, MS, is Instructor in Orthopedic Surgery at Harvard Medical School and the Director of Operations and Strategy at the Center for Healthcare Delivery Sciences, an academic research organization at Brigham and Women’s Hospital (BWH), dedicated to improving health care by identifying, designing, rigorously evaluating, and reporting transformational solutions to engage patients and providers in care delivery
Prior to her role at the Center, Roya led numerous quality improvement and process improvement initiatives at Memorial Sloan Kettering Cancer Center and Brigham and Women’s Hospital. Her interest and passion for improving health care quality stems from her clinical background and experience as a physical therapist and her desire to promote seamless, multidisciplinary and evidence-based care for patients. Over the past 20 years, she has designed and led numerous programs to reduce unnecessary variation in practice and improve collaboration and communication among teams. A dedicated clinician and educator, Roya has co-authored numerous publications in physical therapy, orthopedic outcomes research, quality improvement and health services research.
Richard Gitomer is a board certified general internist. Dr. Gitomer received his medical degree from Emory University, and completed residency and fellowship in internal medicine at Emory University Affiliated Hospitals. Following fellowship, Dr. Gitomer started his own primary care practice in Atlanta and joined the Emory Clinic in 1992. After 24 years at the Emory Clinic, Dr. Gitomer moved to Boston to accept the directorship of Brigham & Women’s Primary Care Center of Excellence.
Donald Goldmann focuses on deepening the credibility of improvement science and expanding its boundaries by incorporating methods from other related disciplines. He has performed studies across the entire continuum of translational research. He explores innovative ways to teach and learn and is lead faculty for the HarvardX/IHI MOOC on Practical Improvement Science. He is senior mentor for IHI’s Fellowship Programs and continues to mentor emerging investigators at Harvard, enabled by Federal T32 Pediatric Health Services Research Training Grants. He advocates for closer integration of improvement science and technology, with the goal of accelerating progress towards equity and population health. He serves on the AHRQ NAC and the Boards of AcademyHealth and the Institute for Medicaid Innovation. He is a Professor of Immunology and Infectious Diseases, and Epidemiology at the Harvard T.H. Chan School of Public Health, and Clinical Professor of Pediatrics at Harvard Medical School.
Susan Haas is co-PI for Ariadne Labs’ CRICO-funded work focused on reducing health care system expansion risks to patient safety. She oversees the planning and execution of the expansion risks work to design and test tools to be used prior to (elucidating the risks) and after affiliation ( prioritizing and mitigating the risks). Current work focuses on: 1) Understanding the risks to patients when physicians are sent to practice part-time in an unfamiliar affiliated hospital and developing risk mitigation tools; and 2) Understanding the mechanisms of risk surrounding decision and implementation to transfer patients between affiliated hospitals.
Joaquim Havens MD, is investigating the burden of emergency general surgery in the United States. He has developed and tested the use of an emergency general surgery checklist and intra-operative huddle under a grant from CRICO. In collaboration with Johnson and Johnson he has helped develop a Device Briefing Tool which has been pilot tested in Thailand and is currently being tested throughout Singapore.
Alex Haynes’ research focuses on improving surgical care delivery through measurement and implementation of quality improvement initiatives. His work bridges environments as diverse as acute care hospitals in South Carolina, where he has been involved in the Safe Surgery 2015 collaborative, to ambulatory surgery centers across the country, as well as hospitals and health systems around the globe. He recently led efforts to report the outcomes of the Safe Surgery 2015 program, finding a significant reduction in postoperative mortality from inpatient surgery paralleling changes in teamwork and communication in the operating rooms. In collaboration with colleagues from the Harvard Business School, Dr. Haynes is running a study to investigate the links between hospital management practices and quality of clinical care, including the ability to implement large-scale quality improvement projects, funded with a research grant from the Rx Foundation. He has also recently launched a collaboration with Dr. JP Onnela of the Harvard T.H. Chan School of Public Health to harness smartphone technology to better understand how surgery affects patient centered outcomes, including physical, emotional, and social well-being. This work will result in methods to measure and assess surgical care, as well as tools for counseling patients and monitoring outcomes outside of the clinical environment.
Dan Henderson is a generalist physician with a passion for leading system improvement. As a Clinical Innovation Fellow and primary care physician at the Massachusetts General Hospital, Dr. Henderson works on redesigning care processes and IT systems around high-risk moments, including transitions from hospital to home and medication prescribing.
Natalie Henrich is the Associate Director of Science and Technology at Ariadne Labs and Technical Lead of the Improvement and Implementation Science Team. In her current role, she works with Ariadne’s project teams to use scientific methods to strengthen the design and measurement of their innovative intervention projects as they progress from initial discovery of solutions through wide-scale spread. Natalie also leads Ariadne Lab’s Context Assessment for Successful Implementation project, which is focused on assessing implementation context and integrating results into implementation strategies, at scale. Throughout her career she has researched and evaluated health issues and programs focusing on effectiveness, acceptability and feasibility, ethicality, and stakeholder needs. Much of her work has dealt with early stages of implementation addressing factors such as barriers and facilitators to acceptance and use, attitudes towards novel innovations and practices, and how communications can be better aligned with stakeholder needs to increase buy-in and enable informed decision-making. Natalie is the co-author of a book, “Why Humans Cooperate.”
David Hepner is a co-investigator on the Ariadne Labs Agency for Health Care Research and Quality Crisis Checklist project. He also serves on the Emergency Manuals Implementation Collaborative Steering Committee with Ariadne Labs.
Ingrid Katz serves as the Associate Faculty Director of the Harvard Global Institute, which comprises a diverse portfolio of cross-cutting global health initiatives across the university. In addition, she maintains an active NIH-funded research program focusing on developing socio-behavioral interventions focused on improving health-seeking behavior among people living with HIV in sub-Saharan Africa. She is also a National Correspondent for the New England Journal of Medicine.
Ravi Kavasery collaborates with the Primary Health Care Performance Initiative in their advisory role to the World Bank engagement with the Estonian Health Insurance Fund. The goal of this work is to improve care transitions, reduce fragmentation of care, and develop an algorithm to identify patients at high risk for poor outcomes based on their history of care utilization, health indicators, and social and behavioral risk factors. As part of this collaboration, Dr. Kavasery has also helped train providers in Estonia on building successful teams and promoting patient empowerment in primary care.
Ramin Khorasani’s current research focuses on use of innovative health IT tools, quality improvement methodologies and change management strategies to improve quality, safety and efficiency of health care care. He published a paper with Dr. Atul Gawande titled “Use of Public Data to Target Variation in Providers’ Use of CT and MR Imaging among Medicare Beneficiaries.” He also presented a talk at an Ariadne Labs’ Innovation meeting titled “Health IT enabled evidence-based practice: Gains, Gaps, and Opportunities.”
Dr. Bharti Khurana is an Assistant Professor in the Department of Radiology at Harvard Medical School and a practicing emergency and musculoskeletal radiologist at the Brigham and Women’s Hospital. She is also the Program Director for Emergency Radiology Fellowship and Clinical Director for Emergency Musculoskeletal Radiology at BWH.
Dr. Khurana is passionate about trauma imaging, particularly optimizing MRI protocols in an emergent setting, providing meaningful imaging interpretations by incorporating a checklist approach and developing machine learning algorithms for injury detection. She believes in harnessing the power of artificial intelligence for radiologists to move beyond clinical diagnosis, collaborate with multidisciplinary care teams, improve overall health outcomes and be an agent of social change. Currently, she is working on establishing the role of radiologists in proactively identifying Intimate Partner Violence (IPV) victims. Additionally, as an associate faculty at Ariadne labs, Dr. Khurana is designing a Clinical Decision Support System (CDSS) and an automated alert generation for IPV detection, for use by the wider community.
Dr. Kuhn is Medical Director for Critical Care at Cambridge Health Alliance and a HMS Clinical Instructor, based in the Division of Pulmonary and Critical Care, Department of Medicine. He also provides attending coverage for the Division of Infectious Diseases, and serves as the co-director of the Thoracic Mass Program at CHA. Dr. Kuhn completed an undergraduate degree at Brown University, and an MD at the Harvard-MIT Health Sciences and Technology Program. He went on to complete Fellowships in Infectious Disease (Case Western/University Hospitals of Cleveland), Critical Care (University of Washington), and Pulmonary Medicine (Partners/MGH). He also conducted basic science research in fungal pathogenesis. His current interests include ICU Quality Improvement, rationalization of resource utilization, care at end-of-life, and modernization of critical care practices in under-resourced settings.
Joshua Lakin serves as the clinical lead for the Serious Illness Care Program at Brigham & Women’s Hospital, both in primary care and general inpatient medicine settings. His recent research focuses on the implementation of the program in primary care. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families.
Daniela Lamas served as the Clinical Lead for the Spaulding Rehabilitation Hospital pilot project testing the acceptability and feasibility of the use of the Serious Illness Care Conversation Guide with chronically critically ill patients and their surrogates. She plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. She also works on clinical and research projects aiming to better understand and improve outcomes for patients who have survived critical illness.
Kimberlyn Leary’s research interests include delineating the components of effective leadership and the interpersonal exchanges that promote change and collaborative decision-making. She also studies the factors that improve health and life outcomes for women and girls, including women and girls of color.
Anne CC Lee, MD, MPH is an Assistant Professor of Pediatrics at Harvard Medical School and practices clinical newborn medicine at the Brigham and Women’s Hospital. She is the Director of Global Newborn Health Research in the Department of Pediatric Newborn Medicine at the BWH. Her primary research focus is the design, implementation, and evaluation of feasible, low-cost and high impact public health interventions to reduce the major causes of perinatal mortality in low-middle income country (LMIC) settings.
Lisa Lehmann is a primary care physician and bioethicist. In addition to her position as the National Center for Ethics in Health Care’s (NCEHC) Executive Director, she is an Associate Professor of Medicine and Medical Ethics at Harvard Medical School and Associate Professor of Health Policy and Management at the Harvard T.H. Chan School of Public Health. Prior to joining NCEHC, Dr. Lehmann practiced primary care and was Director of Bioethics at Brigham & Women’s Hospital. There, she helped develop a robust clinical ethics consultation service and a strong program in ethics education for trainees and hospital staff, developed hospital ethics policy, taught and mentored medical and graduate students, and had an active program of grant-funded empirical and normative research in bioethics. Her research focuses on how to improve care for patients and families at the end of life, the relationship between moral courage, speaking up and patient safety, how to responsibly integrate genomics into clinical medicine, and the intersection of ethics and health policy. Dr. Lehmann was Chair of the Society of General Internal Medicine Ethics Committee, Chair of the Framingham Heart Study Ethics Advisory Board, and Chair of the Harvard Medical School Scholars in Medicine Medical Humanities Advisory Committee. She is a member of the American College of Physicians Ethics, Professionalism and Human Rights Committee.
Jeff Levin-Scherz is a senior director and the co-leader of North American Health Management Practice at Willis Towers Watson, where he helps large employers develop, implement and evaluate their health management strategy, including care management programs, incentive programs, and technology programs.
Jeff leads intellectual capital development for Willis Towers Watson in the Health Management space. Jeff has written and spoken widely on health care reform, especially around the adoption of disruptive innovation, and the use of behavioral economics to drive performance in the health care delivery system and behavior among employees and in the general population. His work has been published in JAMA, the Journal of General Internal Medicine, and the Harvard Business Review.
Jeff has a broad range of experience in health care delivery and finance. He served as a physician executive leader of provider organizations including a large independent practice association, an integrated delivery network, a multispecialty group practice, and a venture-funded technology enabled national primary care practice. He also served for seven years as a vice president of a top-ranked regional health plan. Jeff has been a participant in technical expert panels convened by the Centers for Medicare and Medicaid Services, the Institute of Medicine and the Urban Institute.
Jeff is an Assistant Professor at the Harvard TH Chan School of Public Health, where he teaches courses on provider payment and managing health care costs. He has given guest lectures frequently, including at Columbia University’s Mailman School of Public Health and The Wharton School at the University of Pennsylvania. Jeff has an MD from the Boston University School of Medicine, and received his MBA from Columbia Business School.
David Levine is a practicing general internist and investigator at Brigham & Women’s Hospital and Harvard Medical School. His research focuses on digital health, care redesign, and the quality of delivered health care. He believes fast iterative design grounded in robust research methodology yields results. Among other projects, his team runs a home hospital randomized controlled trial to bring acute care to acutely ill adults as a substitute for traditional hospitalization. They are deploying remote wireless monitoring, predictive analytics, and high-touch care in the home.
Stuart Lipsitz is a biostatistician at Ariadne Labs, and is heavily involved in virtually all programs and research at Ariadne Labs. His specialty is advanced statistical methods, and he has developed new techniques that are widely used in studies with missing data, repeated measures studies, and complex sample surveys.
Ernest Mandel serves as the Clinical Lead for the Dana-Farber Cancer Institute-Brigham & Women’s Faulkner Hospital project studying the adaptability and feasibility of integrating the Serious Illness Care Program into a busy dialysis center. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for clinicians to conduct discussions about end-of-life goals and preferences with seriously ill patients and their families.
Kenneth Mandl works at the intersection of population and individual health with a focus on biomedical informatics. He received a Presidential Early Career Award for Scientists and Engineers for pioneering real time biosurveillance, tracking infections, and detecting outbreaks with diverse data. Dr. Mandl developed SMART, a widely adopted, highly influential approach, to enabling substitutable iPhone-like apps that run universally on health IT systems. He most recently presented his work in a talk entitled “Building the App Store for Public Health: A Perfect Storm” at an Ariadne Labs’ Innovation meeting.
Duncan Maru collaborates on grants and implementation research methodologies with Ariadne staff and faculty. He is the co-founder, chief strategy officer, and a board member of Possible, a non-profit health care company that delivers high-quality, affordable health care in rural Nepal on a public-private partnership model. Possible’s staff of approximately 250 cares for over 130,000 patients per year. Dr. Maru oversees the vision and execution of Possible’s work in government partnerships, impact evaluation, and implementation science. Possible has deployed an open-source electronic medical record (EMR) that integrates care from community health care workers to clinics and hospitals. Through this EMR, Possible aims to implement quality improvement practices, perform surveillance, and conduct rapid, low-cost randomized evaluations of delivery innovations.
Kate Miller supports quantitative research designs, statistical analyses, and mixed-methods approaches across Ariadne’s research portfolio, including the Better Birth, Serious Illness, and Primary Health Care initiatives. Dr. Miller’s interests include innovative research designs, implementation science, quality of care, and women’s health.
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. As the Clinical Editor for NEJM Catalyst, she is part of the founding leadership team and has responsibility for content strategy and quality. She has been part of the founding Population Health and ACO leadership teams at both Partners Health Care and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. Her responsibilities have included designing and implementing ACO strategies for Medicare, Medicaid, and Commercial populations, with a focus on scaling tailored clinical interventions, integrating analytics and measurement, and leading change management and team-based care with providers. Dr. Mohta also has industry experience as a management consultant with the Boston Consulting Group. She often consults with start-ups (currently with PatientPing, GNS Healthcare, and Day Health Strategies) to provide strategic and technical expertise and leadership. Dr. Mohta practices internal medicine at the Brigham and Women’s Hospital and is faculty at The Center for Healthcare Delivery Sciences and at Harvard Medical School. She completed her Internal Medicine and Primary Care residency training at the Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
Rose Molina, MD, MPH is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She works as a board-certified obstetrician-gynecologist at The Dimock Center and Beth Israel Deaconess Medical Center. She completed the Global Women’s Health Fellowship at Brigham and Women’s Hospital and obtained a Master of Public Health in Clinical Effectiveness from the Harvard T.H. Chan School of Public Health. Dr. Molina works as Associate Faculty at Ariadne Labs to design, test and spread solutions to ensure that every woman receives appropriate, safe, and respectful care during pregnancy and childbirth. Her current research focuses on improving shared decision-making in obstetric care. Her current advocacy work seeks to advance access to language-concordant and culturally-humble health care for all, especially undocumented immigrants in the United States. Dr. Molina also serves as a Women’s Health Advisor for Partners In Health in Chiapas, Mexico, an organization she has worked with since 2008.
Gordon Moore is Professor of Population Medicine at HMS. He trained at the Massachusetts General Hospital. In the late 1960’s he joined the founding group of Harvard Community Health Plan, the country’s first academically sponsored HMO, where he eventually became medical director and chief operating officer. While there, he built its first health center in Cambridge, Massachusetts and practiced as a primary care internist there for 40 years. In his academic work he designed and started the New Pathway, a new curriculum at Harvard that has become a worldwide model for medical education. He later became program director of the Robert Wood Johnson initiative to train graduate doctors and nurses in systems thinking and practice improvement. His most special interests are the design, organization, and management of health care delivery systems. He is lead author of Choice Matters: How Healthcare Consumers Make Decisions (and Why Managers and Clinicians Should Care), published by Oxford Press in 2018.
Matthew Mossanen is a urologist at Brigham & Women’s Hospital and Massachusetts General Hospital. Dr. Mossanen received his MD from the David Geffen School of Medicine at the University of California Los Angeles and completed his residency in urology at the University of Washington Medical Center. His research interests involve the quality of, access to, and delivery of cancer care. He received a Partners in Health Policy Grant to support a project that attempts to create a cost-effective, easily scalable program to help cancer patients, especially the elderly and frail, prepare for morbid operations. He supports the use of checklists in the pre-operative period to help cancer patients, caregivers, and providers by focusing on high-yield tasks. Dr. Mossanen is interested in improving the quality of care provided to cancer patients in the US and abroad.
Dr. Ruvandhi Nathavitharana is a TB researcher and attending physician in Infectious Diseases at Beth Israel Deaconess Medical Center and Harvard Medical School. She graduated from Imperial College Medical School London with honors and obtained her MPH from Harvard School of Public Health as a UK Kennedy Scholar. Dr. Nathavitharana completed internal medicine residency at NYU/Bellevue Hospital and trained in Infectious Diseases at Beth Israel Deaconess Medical Center.
TB has re-emerged as the leading cause of death due to an infectious disease globally. TB transmission from patients with unsuspected disease is the major driver of TB incidence. Dr. Nathavitharana’s research interests center around using implementation science to optimize diagnostic strategies to decrease TB transmission. Dr. Nathavitharana is also the Vice Chair of TB Proof, an advocacy organization that seeks to destigmatize TB and mobilize national and global resources to end TB.
Dr. Larissa Nekhlyudov is an Associate Professor in the Department of Medicine at Harvard Medical School and is a practicing internist at the Brigham & Women’s Hospital in Boston, Massachusetts. She is also Clinical Director, Internal Medicine for Cancer Survivors at the Dana-Farber Cancer Institute where she offers clinical consultations for long term survivors of childhood and adult cancers. Dr. Nekhlyudov is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care. Over the past decade, Dr. Nekhlyudov has been at the forefront of the field of cancer survivorship, including the development of survivorship care policies and clinical guidelines, educational programs and research. She is an active member of the Society of General Internal Medicine, the American Society of Clinical Oncology, the National Comprehensive Cancer Network and served on committees at the National Academies of Sciences, Engineering and Medicine (formerly the Institute of Medicine).
JP Onnela’s research focuses on statistical analysis and mathematical and computational modeling of social and biological networks and their connection to human health. His other main research area is digital phenotyping. Prior to joining the Department of Biostatistics at the Harvard T.H. Chan School of Public Health in November 2011, he was a Postdoctoral Research Fellow at Harvard Medical School, a Fulbright Visiting Scholar at the Harvard Kennedy School, and a Junior Research Fellow at Oxford University. He obtained his doctorate at the Helsinki University of Technology in 2006. He received National Institute of Health Director’s New Innovator Award in 2013.
Kei Ouchi, as a practicing emergency physician, is passionate about providing goal-concordant care to older adults with serious illness in the emergency department. As an associate faculty a part of the Serious Illness Care Program at Ariadne Labs, he believes in the emergency department’s potential role to serve as the screening point for such patients and align their preferences to the care they receive towards the end of life. Dr. Ouchi is currently developing and testing a screening strategy to identify such patients and facilitate their advanced care planning process during or after their emergency department visit.
Erika Pabo works on transforming the health care system to better meet the needs of individual patients and populations at a cost that is sustainable to society over time. Pabo currently serves as Chief Health Officer for Humana Edge, an internal startup supported by Humana to transform care and opportunity for seniors. She sees patients as a primary care provider at Brigham and Women’s Advanced Primary Care Practice, South Huntington, a Patient Centered Medical Home, as well as on the inpatient Intensive Teaching Unit at Brigham and Women’s Hospital. She is also Associate Faculty at Ariadne Labs and an Instructor in Medicine at HMS. Pabo also provide consulting services to health care delivery and health care technology companies, incubators and investors.
She previously served as the Associate Medical Director for Primary Care, focused on primary care growth, operational improvement, and care delivery innovation as well as Medical Director for Central Population Management overseeing the population health management portfolio for all primary care’s covered lives. She previously worked at Twine Health, Harvard Medical School Center for Primary Care, the Institute for Healthcare Improvement and the Global Health Delivery Project.
Pabo earned a BA in History of Medicine from Yale College, a medical degree from Harvard Medical School and an MBA from Harvard Business School. She completed her residency in Internal Medicine and Primary Care at Brigham and Women’s Hospital and is ABIM board certified in Internal Medicine.
Joanna (Jo) Paladino is a palliative care physician, implementation specialist, educator, and researcher. She currently serves as the Director of Implementation for the Serious Illness Care Program at Ariadne Labs. The serious illness care team has developed an evidence-based program that includes communication tools, clinician training, and systems-changes. Jo’s research in a randomized controlled trial in oncology demonstrates that the program leads to more, earlier, and better conversations about patients’ values and goals in serious illness, as well as significant improvements in patient well-being. To translate this research into measurable and lasting improvements in communication and care on a broad scale, Jo is the clinical lead for a project that expands this model to health systems throughout the country. She is also one of a small group of faculty educators and has trained hundreds of clinicians to have compassionate and effective serious illness conversations with their patients. Jo earned her MD from Weill Medical College of Cornell University and is board certified in internal medicine and palliative care. She lives with her husband Savan in Boston, Massachusetts.
Richard Platt, MD, MSc is Professor and Chair of the Harvard Medical School Department of Population Medicine at the Harvard Pilgrim Health Care Institute. He is principal investigator of the FDA’s Sentinel System that studies of the safety and effectiveness of marketed medical products. Dr. Platt is also co-principal investigator of the coordinating center of PCORI’s Patient Centered Outcomes Research Institute, leads the NIH Health Care Systems Research Collaboratory’s Distributed Research Network, and is co-principal of a CDC Prevention Epicenter. He is a member of the Association of American Medical Colleges’ Advisory Panel on Research. He is a former chair of the FDA’s Drug Safety and Risk Management Advisory Committee, and co-chair of the Board of Scientific Counselors of the Centers for Disease Control and Prevention’s (CDC) Center for Infectious Diseases.
Audrey Provenzano MD, MPH is an internist who specializes in the care of vulnerable populations. After completing her training in internal medicine and primary care at Brigham and Women’s hospital and the Kraft Fellowship in Community Health Leadership, she joined the faculty at MGH and HMS, where she provides clinical care, supervises trainees, works in quality improvement, writes, and produces a podcast about primary care called Review of Systems with the Harvard Center for Primary Care. She is also on the faculty of the Center for Primary Advancing Teams program which provides technical assistance and training in QI principles in Community Health Centers in the Boston area. Her quality improvement portfolio over the last few years has included developing and implementing a novel fall risk assessment screening and intervention program, improving care after discharge from hospitals, and developing and implementing structured treatment programming for patients with opioid use disorders in the primary care setting.
Yuri Quintana focuses on developing innovative technologies that empower communities of professionals and consumers to collaborate on a worldwide basis. He is currently the Director for Global Health Informatics in the Division of Clinical Informatics, Beth Israel Deaconess Medical Center and Associate Professor in Medicine at Harvard Medical School. Yuri does research and teaching on topics of global health information systems, global e-health applications, clinical informatics, consumer health informatics, mobile health systems, online learning systems, and serious games for health and wellness.
Ruma Rajbhandari, MD, MPH is an Associate Scientist in the Division of Global Health Equity and an Instructor at Harvard Medical School. Her global health focus is on health systems strengthening, human resources for health, quality of care and maternal and child health. Dr. Rajbhandari also serves as the Research Advisor for the Nick Simons Institute, a Nepal-based non-governmental organization whose mission is to innovate solutions in rural healthcare –through training and hospital support– and to advocate for their scale up with the government of Nepal. Her clinical practice is in the Division of Gastroenterology, Hepatology and Endoscopy where her primary interest is viral hepatitis, particularly hepatitis B, and general gastroenterology.
Dr. Rajbhandari is a graduate of the Doris and Howard Hiatt Global Health Equity Internal Medicine Residency Program at Brigham and Women’s Hospital. During residency, she divided her time between Boston and rural clinics and small district hospitals in the impoverished areas of Lesotho, Rwanda and Nepal. While in Nepal, she worked with the Nick Simons Institute and Possible. Currently, she also serves on Possible’s Advisory Board.
Dr. Rajbhandari earned her bachelor’s degree from Yale University, her MD from Harvard Medical School and her MPH from Harvard School of Public Health. She has also completed a fellowship in Gastroenterology and Hepatology at Massachusetts General Hospital, and earned a diploma in Tropical Medicine and Hygiene from the Gorgas Memorial Institute in Lima, Peru.
Raffaella Sadun, an Ariadne Labs SPARK grantee, is focusing her research at Ariadne on the relationship between economics of productivity, management, and organizational change in hospitals. She collaborates with Dr. Alex Haynes, Associate Director of the Safe Surgery Program, on several projects developing methods to measure the quality of health system management, its effect on patient outcomes, and the design and implementation of management improvement programs.
Lipika Samal is a co-SPARK grantee of Ariadne Labs with Associate Faculty Dr. Joseph Jacobson. Their work is focused on improving cancer care delivery. Dr. Samal also researches the use of the electronic health record to improve chronic disease management and care coordination. She is funded by the National Institutes of Health under a research project grant to design and evaluate a clinical decision support system for chronic kidney disease.
Justin Sanders serves as the clinical lead for a project focusing on disparities in care of the seriously ill, as well as a project focusing on the implementation of the Serious Illness Care Program internationally. He plays a key role in the Serious Illness Care Program at Ariadne Labs to develop and evaluate a standardized approach for promoting clinicians to conduct discussions about end-of-life values and goals with seriously ill patients and their families. He was recognized in 2016 as an emerging leader in the field of Palliative Care with a Sojourns Scholar Leadership Award from the Cambia Health Foundation.
Dr. Gordon Schiff is a general internist and Associate Director of Brigham and Women’s Center for Patient Safety Research and Practice, Associate Professor of Medicine at Harvard Medical School, and Quality and Safety Director for the Harvard Medical School Center for Primary Care.
Before coming to Harvard in 2007, he worked for 3 decades at Chicago’s Cook County Hospital where he was professor of Medicine at Rush Medical School and PI of the AHRQ Developmental Center for Patient Safety Research Project focusing on diagnostic errors. He headed the AHRQ PROMISES (Proactive Reduction in Outpatient Malpractice: Improving Safety Efficiency and Satisfaction) malpractice and patient safety improvement project. He was an invited expert and reviewer for the 2015 National Academy of Medicine (IOM) Report: Improving Diagnosis in Health Care. He was recently awarded a grant from the Gordon and Betty More Foundation to create a multifaceted research learning network (PRIDE (Primary-care Research in Diagnosis Errors) to study and improve diagnosis in a number of areas.
Dr. Schiff was PI on a recent FDA CPOE Medication Safety project and White paper, and led the AHRQ-Brigham medication safety HIT CERT CEDAR (Calling for Earlier Detection of Adverse Reactions) Project and a new AHRQ HIT Safety project to enhance electronic prescribing safety by incorporating the drug indication into the prescription order. He is PI on a grant to study issues related to professional-patient boundaries and breakdowns in physician patient relationships funded by the Arnold P. Gold Foundation for Medical Humanism. He chairs the editorial board of Medical Care, and is on editorial board of the Journal Public Health Policy and BMJ Quality and Safety in Healthcare.
Ryan Schwarz is an internal medicine and pediatrics physician at MGH’s Chelsea Health Center, and faculty at the Division of Global Health Equity at Brigham & Women’s Hospital. Ryan was previously the COO and CEO of Possible, a public-private partnership with Nepal’s Ministry of Health & Population, and continues his work in Nepal as a strategic advisor. Ryan was a founding member of the Community Health Impact Coalition, a global coalition of organizations working with multilaterals, development banks, and governments, to improve the design and implementation of community health worker programs. Ryan also serves as a technical consultant with the World Bank and Global Financing Facility on their integrated healthcare delivery platforms.
Dan Schwarz, MD MPH is the Director of Primary Health Care at Ariadne Labs. Dan brings over a decade of global experience in healthcare delivery.
Prior to joining Ariadne Labs, Dan served as the Executive Director, and then Chief Medical Officer for Possible (www.possiblehealth.org), in which role he helped to build and lead an innovative public private partnership for healthcare delivery with the Nepali Ministry of Health. This work now spans multiple districts throughout Nepal, providing both facility- and community-based services to over 500,000 people. Now at Ariadne, Dan continues to serve as a Strategic Adviser to the organization and the Nepali government. Before his work in Nepal, Dan has also worked for Partners In Health (www.pih.org) in multiple countries, and several other non-governmental organizations throughout sub-Saharan Africa and southern Asia. Dan serves as an adviser to the World Health Organization in their Primary Healthcare Measurement Initiative, and an adviser to the Lancet Commission on Noncommunicable Diseases and Poverty.
Mahek A. Shah leads and directs the Value Measurement for Health Care projects at Harvard Business School. As Senior Researcher and Senior Project Director, he designs and implements time-driven activity-based costing (TDABC) globally to help providers, governments, and employers understand real and actual costs of care delivery. He focuses on maximizing value for all stakeholders through reorganization of care delivery, disruptive innovation, and improving the health care experience for all. Dr. Shah is also Associate Faculty at Ariadne Labs and serves on the Board of Operation Airway. He has spent his career at the intersection of health, business, and technology.
Dr. Shah is the co-author of several Harvard Business School (HBS) case studies. His research has been published in the Journal of the American Medical Association (JAMA), World Health Organization (WHO), the Wall Street Journal, New York Times, and Forbes. Shah delivered a TEDx talk at Harvard: Bringing Patient-centered Design to Healthcare. Shah speaks globally on the future of health care delivery, value-based care, innovative delivery models, and the business of healthcare.
Prior to medicine, Dr. Shah worked on Wall Street as an investment banker at Citigroup. Dr. Shah can be found on twitter @Mahek_MD
Neel Shah directs the Delivery Decisions Initiative (DDI) at Ariadne Labs, which aims to ensure every person can start or grow their family with dignity. Dr. Shah’s team is currently implementing the Team Birth Project, a trial involving hundreds of clinicians and tens of thousands of families across the United States that aims to deliver childbirth care is safe, supportive and empowering for every mother, every time. DDI has ongoing collaborations with global stakeholders in maternal health, including health professionals, family advocates, payers, policymakers, employers and others.
Arabella Simpkin is the Associate Director of the Center for Educational Innovation and Scholarship at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. She recently became the inaugural Manager of Innovation Strategy at Harvard Macy Institute. Arabella trained in adult medicine and paediatrics in the UK, and holds Membership to the Royal College of Paediatrics and Child Health.
Arabella’s research focuses on medical decision-making, with particular emphasis on how best to acknowledge and communicate uncertainty. She is committed to designing and researching innovative approaches to the teaching of medicine particularly in diagnostic reasoning, resilience, and embracing uncertainty.
Arabella earned an MA in Physiological Sciences and a medical degree (BMBCh) from Lincoln College at Oxford University, and an MMSc in Medical Education from Harvard Medical School. She is currently enrolled in a DPhil program in the Department of Pharmacology at Oxford University.
Anna D. Sinaiko, PhD is an Assistant Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. She has expertise in health economics and health policy, with a particular focus on consumer decision-making and how information and financial incentives alter consumer behavior in health care settings. Specific empirical projects include an examination of consumer response to tiered physician networks, of the impact of a web-based price transparency tool, and of choice of health insurance plans in Medicare and in private insurance.
A Board-certified medical geneticist and Director of the Down Syndrome Program at Massachusetts General Hospital, Dr. Skotko has dedicated his professional energies toward children with cognitive and development disabilities.
Douglas S. Smink, MD, MPH is an Associate Professor in Surgery at Harvard Medical School and a minimally invasive general surgeon at Brigham and Women’s Hospital. His clinical interests include abdominalwall hernias, foregut surgery, and biliary tract disease. Dr. Smink trained in general surgery at Brigham and Women’s Hospital in Boston and in minimally invasive surgery at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire.
Dr. Smink is the program director of the general surgery residency at Brigham and Women’s, the associate chair of education for the BWH Department of Surgery, and the Chief of Surgery at Brigham and Women’s Faulkner Hospital. He serves as the editor-in-chief of the Journal of Surgical Education and as a member of the editorial board ofSCORE (Surgical Council on Resident Education).
Dr. Smink’s research focuses on resident and faculty education throughsimulation, team training, and coaching. He is the co-PI on an NIH grant, the Provider Awareness and Cultural dexterity Toolkit for Surgeons (PACTS) to improve surgeon communication with culturally diverse patients. In addition, he is the co-PI for the Surgical Coaching for Operative Performance Enhancement (SCOPE) Program, where he helps lead a program of peer-coaching among surgeons.
Joshua Sparrow is actively exploring two possible collaborations with Ariadne Labs: one with Dr. Katherine Semrau’s perinatal work as part of the BetterBirth Program, and one with the Serious Illness Care Program about using online simulation professional development tools for end of life health care provider and patient conversations.
Donna Spiegelman is one of the few people in the world with a joint doctorate in Biostatistics and Epidemiology. As a result, she can freely speak the languages of both disciplines, and switch between the two cultures, playing the role of interlocutor for either. She is the statistician for the Nurses’ Health Study 2, the Health Professionals Follow-up Study, the Pooling Project of Prospective Studies of Diet and Cancer in Men and Women, the Harvard PEPFAR Dar es Salaam site, Trials of Vitamins in Dar es Salaam, and the multitude of projects spawned by these efforts. Her research is motivated by problems which arise in epidemiology and require biostatistical solutions. Dr. Spiegelman’s website is one of the most visited at the Harvard T.H. Chan School of Public Health (HSPH), because it contains much user-friendly well-documented freeware implementing non-standard methods useful in epidemiologic research. Dr. Spiegelman’s most recent interest has been to work with various departments in an interdisciplinary effort to greatly increase global public health efforts at HSPH. In particular, Dr. Spiegelman is interested in developing, testing, and implementing preventive interventions to abate global cancer, diabetes and cardiovascular disease epidemics and offers her expertise in monitoring and evaluation to this end. Dr. Spiegelman and her doctoral student collaborate with BetterBirth through examining the use of pilot data to understand programmatic changes and “learning-by-doing” models of implementation science.
Ariel Dora Stern’s research focuses on empirical analysis of health care markets, health care policy, and studying innovations in medical technology, pharmaceuticals, and health care delivery. She is interested in several topics related to the determinants of health care spending, regulatory policy, and the adoption of health technology, as well as the role of digitalization in products and services.
Thomas Tsai, MD, MPH will join the faculty of Brigham and Women’s Hospital and Harvard Medical School as an Assistant Professor of Surgery in 2019. He received his MD from Stanford University School of Medicine and his MPH from the Harvard T.H. Chan School of Public Health. His clinical expertise is in minimally-invasive surgical management of benign disorders of the esophagus and stomach; obesity and metabolic syndrome; and abdominal wall reconstruction.
Dr. Tsai is an expert on the effect of health reform on the delivery of high-value surgical care. He previously served as a senior advisor to the Assistant Secretary for Planning and Administration in the US Department of Health and Human Services under the Obama Administration where his portfolio included developing the enrollment strategy and model for the Affordable Care Act Health Insurance Marketplace and understanding disparities in Medicare Advantage. His research has helped establish readmissions, patient experience, and hospital management practices as measures of surgical quality. More recently, his research has focused on payment and delivery system reform by understanding the relationship between inpatient quality and post-acute care utilization under episode-based bundled payment models. Dr. Tsai’s work has been published in the New England Journal of Medicine, JAMA, Health Affairs, Lancet, and Annals of Surgery.
Rebecca Weintraub leads the Global Health Delivery Project, generating public goods for professionals delivering value based health care. This includes the Cases in Global Health Delivery (GHD), the first case collection offered at no cost with Harvard Business Publishing. In 2009, Weintraub launched a pilot program with UpToDate (UTD) to grant free subscriptions to UpToDate content to physicians, nurses, and other health workers caring for vulnerable populations. Today providers in 116 countries access this evidence based clinical resource. In addition, GHD has been researching the impact of UTD on medical students in sub-Saharan Africa. She is a co-director of our Ariadne Labs’ Innovation meetings and an active member of our Associate Faculty working group.
Roger Weiss served on the Ariadne Labs team that developed a physician checklist for better prescribing of opioids for people with chronic pain in order to create the proper balance of providing adequate pain treatment while reducing the risk of misuse and overdose. Developed for the Centers for Disease Control and Prevention, the tool guides primary care providers in a strategy that involves setting explicit goals for prescriptions, starting with brief trials first, stopping use when improvement in patient function with chronic pain is not achieved, and enabling regular reassessment. This checklist has rapidly entered wide use.
Dr. Weitberg serves as the Director of the Atrius Health Academic Institute where he oversees the development and implementation of all research and educational programs at Atrius Health. The Academic Institute is comprised of Centers for Clinical Research, Education, Analytics & Informatics and Healthcare Innovation. A major research interest of the Institute is redesigning care delivery to improve clinical outcomes, focus on patient-centered care innovation and reduce provider burnout by streamlining workflows. A multi-year project with IBM Watson Health is in progress to develop innovative tools in the workplace to reduce provider work burden while offering therapeutic options in real time. Multiple grant partners exist both locally and nationally in a variety of funded projects including medication adherence, telemedicine, childhood obesity, NLP research and Medically Home.
Chris Wong-Quiles collaborates with Ariadne Labs project “Making it Easier to Care for a Central Line at Home.” The project aims to reduce ambulatory CLABSI (Central Line Associated Bloodstream Infections) in pediatric hematology-oncology patients. They are doing this by developing a knowledge and skill development program that ensures that all caregivers in the home adhere to standardized care bundle and feel confident performing line care.
Zayed Yasin is the Assistant Director of the Division of International Collaborations in the Department of Emergency Medicine at the Brigham & Women’s Hospital. Dr. Yasin focuses on the intersection between Population Health and Acute Care Systems, and is currently working on projects to improve emergency care systems in Sweden and India.
Steven Yule is a leading academic psychologist and internationally recognized for his research on non-technical skills and patient safety in surgery. Most notably, he was one of the pioneers of the ‘Non-Technical Skills for Surgeons’ behavior observation system, which is now being implemented for surgical education and research in North America, Europe, Australia, Africa and Asia. Dr. Yule has authored several seminal manuscripts on non-technical skills, edited the first surgical textbook on the topic, and leads a research laboratory dedicated to advancing the field. His current research focuses on the relationship between clinicians’ behavior and patient outcomes, use of technology to automate surgical team assessment, and developing simulation-based support for astronauts to manage medical events on deep space missions. He is vice chair of the American College of Surgeons committee on non-technical skills and education chair of Association for Academic Surgery.
Michael Zalis serves as the chief medical officer of QPID Health, a medical informatics company based in Boston, MA. He is a board certified Radiologist with extensive experience in abdominal imaging, interventional radiology, computer science, and clinical research. Dr. Zalis continues to serve part-time as a staff member of Massachusetts General Hospital and as an associate professor at Harvard Medical School. Clinically, he serves on the abdominal imaging and interventional radiology services at MGH. He also currently direct the program in CT Colonography (aka “Virtual Colonoscopy”) at Massachusetts General Hospital; CT Colonography is a non-invasive method for colon cancer screening.